Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Tirzepatide may drive greater average weight loss in some settings, but semaglutide can still be the better fit when coverage, supply, tolerability, or treatment history points that way
In SUSTAIN-6, patients on semaglutide experienced an average 4 mmHg greater systolic drop than placebo after 30 weeks, independent of weight loss (see the SUSTAIN-6 trial publication )
Ozempics appetite-suppressing effects can alter brain chemistry and potentially reduce dopamine release
Gastrointestinal side effects compound when combining these medications
US$ 27.02
US$ 25.11
US$ 27.07
US$ 27.92
US$ 29.92
